Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Crossref DOI link: https://doi.org/10.1007/s41669-017-0030-7
Published Online: 2017-05-29
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ball, Graeme http://orcid.org/0000-0001-5414-0621
Xie, Feng
Tarride, Jean-Eric
License valid from 2017-05-29